Shares of Tandem Diabetes (NASDAQ:TNDM) (San Diego) were up as high as 12.5% yesterday as the company revealed it had received FDA approval for its t:slim G4 insulin pump. The device is a touch-screen pump with continuous glucose monitoring (CGM) integration, for use by people 12 years of age or older who use insulin. Read More
